CytoTools AG

CytoTools AG
Stock Exchange Xetra Stock Exchange
EPS
EUR0.5
Market Cap
EUR20.14 M
Shares Outstanding
2.12 M
Public Float
-

Profile

Address
Klappacher Strasse 126
Darmstadt Hessen 64285
Germany
Employees -
Website http://cytotools.de
Updated 07/08/2019
CytoTools AG is a biotechnology company, which engages in the research and development of therapies to treat cause of diseases. The company provides treatment options in dermatology, cardiology and angiology, urology, and oncology. Its products and pipeline include DermaPro, CardioClean, Cancer T17-n, and Utisept.

Financials

View All
Created with Highcharts 5.0.14CytoTools AGNet Income. Fiscal year is January-December. All values EUR Thousands.1 1351 1351 0351 0351 3041 3049789781 0651 065201320142015201620170250500750100012501500
Created with Highcharts 5.0.14CytoTools AGSales/Revenue. Fiscal year is January-December. All values EUR Thousands.50503003000000898920132014201520162017050100150200250300350

Manfred May
Chairman-Supervisory Board
Jutta Schnirring-Mayer
Member-Supervisory Board